Literature DB >> 21667306

Low frequency of PIK3CA gene mutations in hepatocellular carcinoma in Chinese population.

Xun Li1, Quanbao Zhang, Wenting He, Wenbo Meng, Jun Yan, Lei Zhang, Xiaoliang Zhu, Tao Liu, Yumin Li, Zhongtian Bai.   

Abstract

PI3K/AKT constitutes an important pathway regulating the signaling of multiple biological processes and plays a critical role in carcinogenesis. PIK3CA gene missense mutations have been reported in many human cancer types. The mutation of it in hepatocellular carcinoma cases varies with different races and regions. In this study, we investigated PIK3CA mutation in Chinese hepatocellular carcinoma patients. A total 90 Chinese patients of hepatocellular carcinoma were recruited in this study. Exons 9 and 20 hotspots mutations of PIK3CA gene were detected by PCR-based DNA sequencing. Two point mutations (E542K and D549H) in exon 9 were found in only one patient (1/90; 1.11%), no mutation was found in exon 20 in any cases. 57 patients are associated with HBV infection (57/90; 63.3%), and 8 patients with HCV infection (8/90; 8.9%). The frequency of the PIK3CA mutations in hepatocellular carcinoma seems to be lower in Chinese hepatocellular carcinoma patients. These findings suggest that PI3K mutations may not play a major role in hepatic carcinogenesis in Chinese. HBV infection has close relationship with HCC in Chinese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667306     DOI: 10.1007/s12253-011-9416-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  25 in total

1.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

2.  PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

Authors:  Jong Woo Lee; Young Hwa Soung; Su Young Kim; Hae Woo Lee; Won Sang Park; Suk Woo Nam; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

3.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

4.  An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

Authors:  Katherine Stemke-Hale; Ana Maria Gonzalez-Angulo; Ana Lluch; Richard M Neve; Wen-Lin Kuo; Michael Davies; Mark Carey; Zhi Hu; Yinghui Guan; Aysegul Sahin; W Fraser Symmans; Lajos Pusztai; Laura K Nolden; Hugo Horlings; Katrien Berns; Mien-Chie Hung; Marc J van de Vijver; Vicente Valero; Joe W Gray; René Bernards; Gordon B Mills; Bryan T Hennessy
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  PIK3CA alterations in Middle Eastern ovarian cancers.

Authors:  Jehad Abubaker; Prashant Bavi; Wael Al-Haqawi; Zeenath Jehan; Adnan Munkarah; Shahab Uddin; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-07-28       Impact factor: 27.401

6.  PIK3CA mutation and amplification in human lung cancer.

Authors:  Koji Okudela; Masaya Suzuki; Shinji Kageyama; Tomoyasu Bunai; Kiyoko Nagura; Hisaki Igarashi; Kazuya Takamochi; Kazuya Suzuki; Takeshi Yamada; Hiroshi Niwa; Riuko Ohashi; Hiroshi Ogawa; Hiroki Mori; Hitoshi Kitamura; Takeshi Kaneko; Toshihiro Tsuneyoshi; Haruhiko Sugimura
Journal:  Pathol Int       Date:  2007-10       Impact factor: 2.534

7.  PIK3CA mutation associates with improved outcome in breast cancer.

Authors:  Kevin Kalinsky; Lindsay M Jacks; Adriana Heguy; Sujata Patil; Marija Drobnjak; Umeshkumar K Bhanot; Cyrus V Hedvat; Tiffany A Traina; David Solit; William Gerald; Mary Ellen Moynahan
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

8.  PIK3CA mutations and copy number gains in human lung cancers.

Authors:  Hiromasa Yamamoto; Hisayuki Shigematsu; Masaharu Nomura; William W Lockwood; Mitsuo Sato; Naoki Okumura; Junichi Soh; Makoto Suzuki; Ignacio I Wistuba; Kwun M Fong; Huei Lee; Shinichi Toyooka; Hiroshi Date; Wan L Lam; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

9.  Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.

Authors:  Marc-Oliver Riener; Marion Bawohl; Pierre-Alain Clavien; Wolfram Jochum
Journal:  Genes Chromosomes Cancer       Date:  2008-05       Impact factor: 5.006

10.  Mutations of PIK3CA in gastric adenocarcinoma.

Authors:  Vivian Sze Wing Li; Chi Wai Wong; Tsun Leung Chan; Agnes Sze Wah Chan; Wei Zhao; Kent-Man Chu; Samuel So; Xin Chen; Siu Tsan Yuen; Suet Yi Leung
Journal:  BMC Cancer       Date:  2005-03-23       Impact factor: 4.430

View more
  5 in total

1.  Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.

Authors:  Wenmin Hou; Jibin Liu; Peizhan Chen; Hui Wang; Bang-Ce Ye; Fulin Qiang
Journal:  Oncol Lett       Date:  2014-06-13       Impact factor: 2.967

Review 2.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

3.  PIK3CA mutations in hepatocellular carcinoma in Korea.

Authors:  Heesue Kim; Cheol-Keun Park; Su Jin Lee; Sun Young Rha; Kyu Hyun Park; Ho Yeong Lim
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

4.  Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity.

Authors:  Ao Huang; Xin Zhang; Shao-Lai Zhou; Ya Cao; Xiao-Wu Huang; Jia Fan; Xin-Rong Yang; Jian Zhou
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207

5.  Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.

Authors:  Alireza Tabibzadeh; Fahimeh Safarnezhad Tameshkel; Yousef Moradi; Saber Soltani; Maziar Moradi-Lakeh; G Hossein Ashrafi; Nima Motamed; Farhad Zamani; Seyed Abbas Motevalian; Mahshid Panahi; Maryam Esghaei; Hossein Ajdarkosh; Alireza Mousavi-Jarrahi; Mohammad Hadi Karbalaie Niya
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.